https://www.macrotrends.net/stocks/charts/PGEN/precigen/revenue
Precigen revenue from 2012 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or...
precigenrevenuepgenmacrotrends
https://stockhouse.com/companies/quote?symbol=pgen
Get today's stock prices, news and investor discussion about Precigen Inc (NDAQ:PGEN). Research PGEN stock prices, stock quotes, stock trends and price history.
stock pricetoday newsquote historyprecigeninc
https://www.pharmaceutical-technology.com/data-insights/prgn-3006-precigen-myelodysplastic-syndrome-likelihood-of-approval/
PRGN-3006 is under clinical development by Precigen and currently in Phase I for Myelodysplastic Syndrome.
myelodysplastic syndromeprgnprecigenlikelihoodapproval
https://www.prnewswire.com/news-releases/precigen-announces-clearance-of-ind-to-initiate-phase-iii-study-for-first-in-class-prgn-2009-adenoverse-immunotherapy-to-treat-hpv-positive-hpv-solid-tumors-301043434.html
/PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve...
precigenannouncesclearanceindinitiate